Biocon Pharma Limited receives GMP compliance certificate from MHRA, UK

Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Medicines & Healthcare products Regulatory Agency (MHRA), the United Kingdom (UK), for its manufacturing facility at Biocon Park in Bengaluru.

The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in the week of 22nd March, 2021, in the wake of travel restrictions amidst Covid-19.

Shares of BIOCON LTD. was last trading in BSE at Rs.420.3 as compared to the previous close of Rs. 413.2. The total number of shares traded during the day was 133792 in over 2076 trades.

The stock hit an intraday high of Rs. 424.1 and intraday low of 413.15. The net turnover during the day was Rs. 56102993.

Source : Equity Bulls

Keywords